Compare ODD & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ODD | BME |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 651.3M | 593.0M |
| IPO Year | 2022 | 2005 |
| Metric | ODD | BME |
|---|---|---|
| Price | $13.75 | $45.81 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 759.5K | 39.1K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.92 | N/A |
| P/E Ratio | $16.73 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.25 | $35.95 |
| 52 Week High | $64.23 | $46.43 |
| Indicator | ODD | BME |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 65.10 |
| Support Level | $13.98 | $39.51 |
| Resistance Level | $14.61 | $46.43 |
| Average True Range (ATR) | 0.86 | 0.56 |
| MACD | 0.17 | -0.07 |
| Stochastic Oscillator | 68.52 | 77.85 |
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.